is wegovy a glp-1 drug U.S. Obesity Rate Drops As Usage Grows US FDA accepts Novo Nordisk's
Description
SGLT2 inhibitors are indicated for three conditions: T2DM, chronic kidney disease, and chronic heart failure

In theory, the transfer to human milk of GLP-1 agonists may be low, as they are large peptide molecules ( Supplement 3 )

One major barrier to GLP-1RA treatment is the reluctance of some patients to inject
:max_bytes(150000):strip_icc()/VWH-GettyImages-2275860768-a6f6e63304e048d0a829844c1dacbd8d.jpg)
Science Translational Medicine , 15

Journal of Clinical Endocrinology & Metabolism , 93(12), 4600-4605
DeVries, S
